| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| mrna and cancer risk | 0.39 | 0.3 | 3433 | 61 | 20 |
| mrna | 0.94 | 0.8 | 628 | 72 | 4 |
| and | 0.79 | 0.1 | 5674 | 89 | 3 |
| cancer | 0.99 | 0.5 | 5974 | 2 | 6 |
| risk | 0.43 | 0.4 | 2282 | 38 | 4 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| mrna and cancer research | 1.36 | 0.4 | 4901 | 51 |
| mrna and cancer studies | 1.8 | 0.1 | 1795 | 32 |
| risks of mrna treatment | 1.84 | 0.7 | 3402 | 46 |
| targeting cancer with mrna | 1.19 | 0.4 | 6595 | 1 |
| mrna and cancer treatment | 0.18 | 0.1 | 9348 | 94 |
| mrna in cancer therapy | 1.07 | 0.1 | 6781 | 86 |
| is mrna being used to treat cancer | 1.92 | 0.1 | 8471 | 29 |
| mrna treatment for cancer | 1.13 | 0.8 | 1930 | 33 |
| risk of mrna vaccines | 0.65 | 1 | 8963 | 6 |
| mrna technology for cancer | 0.69 | 0.2 | 2790 | 63 |
| mrna effects on humans | 1.04 | 0.6 | 3253 | 99 |
| is mrna safe in the long term | 1.58 | 0.5 | 5406 | 46 |
| mrna risk group biosafety | 0.28 | 0.9 | 8530 | 87 |
| current developments and challenges of mrna | 0.7 | 0.3 | 119 | 88 |
| impact and effectiveness of mrna | 1.93 | 0.6 | 4619 | 37 |
| is mrna technology safe | 1.8 | 0.5 | 376 | 8 |
| mrna based cancer therapeutics | 1.29 | 0.7 | 2961 | 93 |
| mrna safety long term | 1.94 | 0.7 | 9968 | 48 |
| mrna in the news | 1.71 | 0.2 | 2134 | 35 |
| does mrna affect dna | 1.1 | 0.8 | 8398 | 85 |
| mrna cancer research | 1.58 | 0.5 | 9996 | 89 |
| mrna for cancer therapy | 0.76 | 0.9 | 5231 | 15 |
| mrna technology cancer treatment | 0.12 | 0.4 | 2640 | 27 |
